Phase 2 study of pembrolizumab in patients with recurrent and residual high-grade meningiomas
帕博利珠单抗治疗复发性和残留性高级别脑膜瘤患者的II期研究
期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-022-29052-7
Brastianos, Priscilla K; Kim, Albert E; Giobbie-Hurder, Anita; Lee, Eudocia Quant; Wang, Nancy; Eichler, April F; Chukwueke, Ugonma; Forst, Deborah A; Arrillaga-Romany, Isabel C; Dietrich, Jorg; Corbin, Zachary; Moliterno, Jennifer; Baehring, Joachim; White, Michael; Lou, Kevin W; Larson, Juliana; de Sauvage, Magali A; Evancic, Kathryn; Mora, Joana; Nayyar, Naema; Loeffler, Jay; Oh, Kevin; Shih, Helen A; Curry, William T; Cahill, Daniel P; Barker, Fred G; Gerstner, Elizabeth R; Santagata, Sandro